- ￥1338 - 11148
- abinScience
- France
- VK521063
- 2026年04月26日
- ELISA: 1:2000-1:20000
- Human
- Hendra virus, Nipah virus
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
VHH-Fc
- 形态：
Liquid
- 保存条件：
-20°C
- 克隆性：
单克隆
- 适应物种：
Hendra virus, Nipah virus
- 保质期：
twelve months
- 级别：
一抗
- 供应商：
武汉益普生物科技有限公司
- 宿主：
Human
- 应用范围：
ELISA: 1:2000-1:20000
- 抗体英文名：
Anti-HeV/NiV Fusion Protein Antibody (DS90)
- 规格：
50μg/100μg/1mg
| 规格： | 50μg | 产品价格： | ￥1338.0 |
|---|---|---|---|
| 规格： | 100μg | 产品价格： | ￥2288.0 |
| 规格： | 1mg | 产品价格： | ￥11148.0 |
| 产品名 | Anti-HeV/NiV Fusion Protein Antibody (DS90) |
| 货号 | VK521063 |
| 宿主 | Human |
| 种属反应性 | Hendra virus, Nipah virus |
| 克隆类型 | Monoclonal |
| 克隆号 | DS90 |
| Accession号 | Q9IH63, O89342 |
| 靶标 | Fusion glycoprotein F0, Protein F, Fusion glycoprotein F2, Fusion glycoprotein F1, F |
| 同种型 | VHH-Fc |
| 应用 | ELISA, SPR, Neutralization |
| 应用范围 | ELISA: 1:2000-1:20000 |
| 内毒素水平 | Please contact with the lab for this information. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 纯度 | >95% as determined by SDS-PAGE. |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS pH 7.4 |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 说明 | For research use only. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Expression of Antibody Fusion Proteins in Mammalian Cells
range of recombinant molecules have now been constructed where the binding specificity of an antibody or T-cell receptor variable domain, cytokine, growth factor, or other protein ligand (e.g., CD4) is fused to another protein domain, for example
Expression of Recombinant Antibody Fusion Proteins in E. coli
of the antibody moiety, and local cytotoxic action is determined by the foreign protein. Examples of this approach include immunotoxins, in which the effector protein is a plant or bacterial toxin (1 ), and antibody-directed enzyme prodrug therapy (ADEPT
Antibody-IL2 Fusion Proteins for Tumor Targeting
as part of an antibody-cytokine fusion protein to the tumor tissue by a single chain fragment of variable regions (scFv) antibody recognizing a tumor-associated antigen. IL2 can moreover be combined with IL12 in a dual cytokine fusion protein, which simultaneously
技术资料暂无技术资料 索取技术资料
